Cargando…

Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription

Tuberculosis (TB) remains one of the deadliest infectious diseases in the world. Although several established antitubercular drugs have been found, various factors obstruct efforts to combat this disease due to the existence of drug-resistance (DR) TB strains, the need for lengthy treatment, and the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephanie, Filia, Saragih, Mutiara, Tambunan, Usman Sumo Friend, Siahaan, Teruna J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506182/ https://www.ncbi.nlm.nih.gov/pubmed/36143370 http://dx.doi.org/10.3390/life12091333

Ejemplares similares

M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts
por: Stephanie, Filia, et al.
Publicado: (2022)

Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment
por: Stephanie, Filia, et al.
Publicado: (2021)

Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Identification of DNA Methyltransferase-1 Inhibitor for Breast Cancer Therapy through Computational Fragment-Based Drug Design
por: Alkaff, Ahmad Husein, et al.
Publicado: (2021)

Screening of commercial cyclic peptide as inhibitor NS5 methyltransferase of Dengue virus through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2014)

Designing cyclopentapeptide inhibitor as potential antiviral drug for dengue virus ns5 methyltransferase
por: Idrus, Syarifuddin, et al.
Publicado: (2012)

Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

Identification of sequence mutations affecting hemagglutinin specificity to sialic acid receptor in influenza A virus subtypes
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
por: Ulapane, Kavisha R., et al.
Publicado: (2019)

Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2013)

Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens
por: Bakri, Ridla, et al.
Publicado: (2014)

Immunoinformatics Approach in Designing Epitope-based Vaccine Against Meningitis-inducing Bacteria (Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae Type b)
por: Zahroh, Hilyatuz, et al.
Publicado: (2016)

Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2016)

Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
por: Nasution, Mochammad Arfin Fardiansyah, et al.
Publicado: (2018)

Immune Modulation by Antigenic Peptides and Antigenic Peptide Conjugates for Treatment of Multiple Sclerosis
por: Mahadik, Rucha, et al.
Publicado: (2022)

Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Exposing the Molecular Screening Method of Indonesian Natural Products Derivate as Drug Candidates for Cervical Cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2017)

Modulation of Blood–Brain Barrier Permeability in Mice Using Synthetic E-Cadherin Peptide
por: On, Ngoc H., et al.
Publicado: (2014)

Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in Mycobacterium tuberculosis
por: Manikandan, Kasi, et al.
Publicado: (2014)

Evaluation of LFA-1 Peptide-Methotrexate Conjugates in Modulating Endothelial Cell Inflammation and Cytokine Regulation
por: Yusuf-Makagiansar, Helena, et al.
Publicado: (2023)

Correction: Two-Step Synthesis and Hydrolysis of Cyclic di-AMP in Mycobacterium tuberculosis
Publicado: (2014)

Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal
por: Badawi, Ahmed H, et al.
Publicado: (2014)

Detection of Mycobacterium tuberculosis and Mycobacterium bovis in Sahiwal cattle from an organized farm using ante-mortem techniques
por: Filia, Gursimran, et al.
Publicado: (2016)

Design and Synthesis of “Chloropicolinate Amides and Urea Derivatives” as Novel Inhibitors for Mycobacterium tuberculosis
por: Konduri, Srihari, et al.
Publicado: (2021)

Cyclic-AMP regulation of protein lysine acetylation in Mycobacterium tuberculosis
por: Lee, Ho Jun, et al.
Publicado: (2012)

Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
por: Zhang, Hai-Nan, et al.
Publicado: (2017)

Cyclic oligoadenylate signalling mediates Mycobacterium tuberculosis CRISPR defence
por: Grüschow, Sabine, et al.
Publicado: (2019)

Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosis
por: Martinez-Grau, Maria Angeles, et al.
Publicado: (2018)

The occurrence of ansamers in the synthesis of cyclic peptides
por: Yao, Guiyang, et al.
Publicado: (2022)

Solid-phase synthesis of cyclic peptide chitinase inhibitors: SAR of the argifin scaffold
por: Dixon, Mark J., et al.
Publicado: (2009)

Wollamide Cyclic Hexapeptides Synergize with Established and New Tuberculosis Antibiotics in Targeting Mycobacterium tuberculosis
por: Rollo, Rachel F., et al.
Publicado: (2023)

Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
por: Lu, Guo-Liang, et al.
Publicado: (2020)

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors
por: Kishk, Safaa M., et al.
Publicado: (2019)

Reprogramming the Transcriptional Response to Hypoxia with a Chromosomally Encoded Cyclic Peptide HIF-1 Inhibitor
por: Mistry, Ishna N., et al.
Publicado: (2016)

The Transcriptional Regulatory Network of Mycobacterium tuberculosis
por: Sanz, Joaquín, et al.
Publicado: (2011)

Recyclable hypervalent-iodine-mediated solid-phase peptide synthesis and cyclic peptide synthesis
por: Liu, Dan, et al.
Publicado: (2018)

Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis
por: Singh, Sheo B., et al.
Publicado: (2018)

Synthesis and Biological Evaluation of Termini-Modified and Cyclic Variants of the Connexin43 Inhibitor Peptide5
por: Crystal Chan, Sin Hang, et al.
Publicado: (2022)

Synthesis of a Poly-hydroxypyrolidine-Based inhibitor of Mycobacterium tuberculosis GlgE
por: Veleti, Sri Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o1utk9go96i1v7s323jt21on5r